Analystreport

Sutro Biopharma Inc (NASDAQ: STRO) had its "buy" rating re-affirmed by analysts at Cowen Inc.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report